Literature DB >> 33216244

Tailored HIV Pre-exposure Prophylaxis (PrEP) Intervention Needs from a Latent Class Analysis Among U.S. Healthcare Providers.

Steven A John1, Jennifer L Walsh2, Benedikt Pleuhs2, Rose Wesche3, Katherine G Quinn2, Andrew E Petroll2.   

Abstract

Interventions are needed to expand HIV pre-exposure prophylaxis (PrEP) prescribing practices among healthcare providers, but research classifying providers to determine tailored intervention needs is lacking. Providers reported demographics, factors related to HIV treatment and prevention experience, and PrEP-related factors such as knowledge and community protection beliefs via online survey. Latent class analysis grouped providers with similar patterns of HIV prevention- and treatment-related care and tested for associations with demographics and PrEP-related factors. Three distinct classes of providers emerged: (1) PrEP naïve, (2) PrEP aware, and (3) PrEP prescribers. Providers with lower community protection beliefs and staff capacity were more likely to be classified as PrEP naïve compared to aware (ps < 0.05). Providers with concerns about PrEP-related tasks and staff capacity were more likely to be classified as PrEP aware compared to prescribers (ps < 0.05). PrEP-naïve providers could benefit from continuing education, whereas PrEP-aware providers might benefit from capacity building and prescribing optimization interventions.

Entities:  

Keywords:  HIV; Post-exposure prophylaxis; Pre-exposure prophylaxis; Prescription; Providers

Mesh:

Substances:

Year:  2020        PMID: 33216244      PMCID: PMC8084873          DOI: 10.1007/s10461-020-03105-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  36 in total

1.  Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2015-01       Impact factor: 5.078

2.  Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance.

Authors:  Gerard J B Sonder; Jan M Prins; Rosa M Regez; Kees Brinkman; Jan-Willem Mulder; Jan Veenstra; Frans A P Claessen; Anneke van den Hoek
Journal:  Sex Transm Dis       Date:  2010-11       Impact factor: 2.830

3.  Roadblocks to PrEP: What Medical Records Reveal About Access to HIV Pre-exposure Prophylaxis.

Authors:  Avy A Skolnik; Barbara G Bokhour; Allen L Gifford; Brigid M Wilson; Puja Van Epps
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

4.  Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.

Authors:  Samuel M Jenness; Kevin M Weiss; Steven M Goodreau; Thomas Gift; Harrell Chesson; Karen W Hoover; Dawn K Smith; Albert Y Liu; Patrick S Sullivan; Eli S Rosenberg
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

5.  A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".

Authors:  Susie Hoffman; John A Guidry; Kate L Collier; Joanne E Mantell; Daria Boccher-Lattimore; Farnaz Kaighobadi; Theo G M Sandfort
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-20

6.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

7.  Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers.

Authors:  Brian R Wood; Vanessa M McMahan; Kelly Naismith; Jonathan B Stockton; Lori A Delaney; Joanne D Stekler
Journal:  Sex Transm Dis       Date:  2018-07       Impact factor: 2.830

8.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

9.  Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.

Authors:  Douglas S Krakower; Norma C Ware; Kevin M Maloney; Ira B Wilson; John B Wong; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2017-06-02       Impact factor: 5.078

10.  PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.

Authors:  Dawn K Smith; Maria C B Mendoza; Jo Ellen Stryker; Charles E Rose
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more
  1 in total

1.  Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.

Authors:  Benedikt Pleuhs; Colleen B Mistler; Katherine G Quinn; Julia Dickson-Gomez; Jennifer L Walsh; Andrew E Petroll; Steven A John
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.